Cc Genotype Donors for the Interleukin-28B Single Nucleotide Polymorphism Are Associated With Better Outcomes in Hepatitis C After Liver Transplant Academic Article uri icon

abstract

  • Interleukin-28B (IL-28B) polymorphism is the strongest pretreatment predictor of viral clearance in the hepatitis C (HCV) population. Donor and recipient IL-28B genomic background may play an important role in post-transplant HCV recurrence. We sought to examine the role of IL-28B polymorphisms of donor and recipients in liver transplant patients with recurrent HCV and its impact on the response to interferon-based therapy.

publication date

  • 2013-01-01